-
1دورية أكاديمية
المؤلفون: Burtness, B, Haddad, R, Dinis, J, Trigo, J, Yokota, T, Viana, LD, Romanov, I, Vermorken, J, Bourhis, J, Tahara, M, Segalla, JGM, Psyrri, A, Vasilevskaya, I, Nangia, CS, Chaves-Conde, M, Kiyota, N, Homma, A, Holeckova, P, Del Campo, JM, Asarawala, N, Nicolau, UR, Rauch, D, Even, C, Wang, BS, Gibson, N, Ehrnrooth, E, Harrington, K, Cohen, EEW, Giglio, RE, Blajman, CR, Freue, JM, Pilnik, NG, Palazzo, FS, McGrath, M, Fureder, T, Kornek, G, Pichler, A, Bauernhofer, T, Tinchon, C, Greil, R, Burian, M, Kienzer, H, Specenier, P, Sautois, B, Debruyne, P, Graas, MP, Maes, A, Lonchay, C, Daisne, JF, Fontaine, C, Castro, G, de Oliveira, F, Pereira, RP, De Marchi, PRM, Lazaretti, NS, Kulkarni, S, Alam, Y, Ho, C, Shenouda, G, Soulieres, D, Sultanem, K, Singh, S, Mella, PG, Campos, JAS, Prausova, J, Obermannova, R, Friborg, J, Specht, L, Elsaid, AA, Minn, H, Martin, L, Rolland, F, Ceruse, P, Calais, G, Guigay, J, Ferte, C, Peyrade, F, Duffaud, F, Champeaux-Orange, E, Coutte, A, Clatot, F, Fournel, P, Le Moal, LB, Dietz, A, Grunwald, V, Gauler, T, Guntinas-Lichius, O, Hildebrandt, G, Kuhnt, T, Schmidt, HJ, Henke, M, Ruckert, A, Brugger, W, Rotter, N, Mahlberg, R, Karavasilis, V, Fountzilas, G, Psyrri, D, Lang, I, Boer, A, Kocsis, J, Pajkos, G, Tamas, L, Anand, AL, Sharma, A, harma, Voona, M, Pandy, AS, Kumar, K, Nathan, RKP, Srinivasan, V, Zade, B, Jain, M, Srinivasa, BJ, Naik, R, Mohanty, BK, Charas, T, Billan, S, Popovtzer, A, Licitra, L, Ferrari, D, Fao, P, Merlano, M, Rocca, MC, Fujii, H, Minami, S, Fujii, M, Kadowaki, S, Muro, K, Okami, K, Yagi, T, Yoshino, K, Matsumoto, K, Takahashi, S, Matsuura, K, Avitia, MAA, Riestra, HJG, van Meerten, E, Buter, J, Gelderblom, AJ, Kawecki, A, Golusinski, W, Dinis, R, Ribeiro, L, Silva, R, Mansinho, H, Selezneva, I, Biakhov, M, Galiulin, R, Izmailov, A, Vladimirov, V, Vinogradov, V, Mufazalov, F, Baste, N, del Campo, JM, Nin, RM, Pousa, AL, de Castro, JJG, Reig, O, Vera, R, Iglesias, L, Trufero, JM, Vazquez, S, Rubio, B, Ales, JE, Villar, E, Rubio, J, Escobar, Y, Soria, A, Chaves, M, Johansson, GW, Friesland, S, Tell, R, Nyman, J, Rothschild, S, Zippelius, A, Usluoglu, N, Gogunska, I, Zabolotniy, D, Vinnyk, Y, Burian, O, Sykes, A, Peel, D, Lester, J, Robinson, M, Srinivasan, D, Fragkandrea-Nixon, I, Junor, E, Gollins, S, Evans, M, Newbold, K, Hwang, D, Schipani, S, Rizwanullah, M, Atiq, O, Arnaoutakis, K, Bauman, J, Mehra, R, Kang, H, Chung, C, Davis, T, Jimeno, A, Keresztes, R, Nangia, C, Ignatius, SH, Su, YB, Overton, LC, Garrison, MA, Jeong, W, Wehbe, A, Argiris, A, Chiang, A, Morgensztern, D, Haigentz, M, Martincic, D, Porosnicu, M
المصدر: JAMA oncology. 5(8):1170-1180
مصطلحات موضوعية: Medicin och hälsovetenskap
-
2دورية أكاديمية
المصدر: Anais da Academia Brasileira de Ciências. January 2019 91(2)
مصطلحات موضوعية: environmental fragility, environmental management, Lapa Grande park, multicriteria analysis
وصف الملف: text/html
-
3دورية أكاديمية
المؤلفون: Golan Y; Tufts Medical Center, Appili Therapeutics, Boston, Massachusetts, USA., Campos JAS; Kohler and Milstein Research S.A. de C.V., Merida, Mexico., Woolson R; Rho, Inc, Durham, North Carolina, USA., Cilla D; Appili Therapeutics, Waterford, Virginia, USA., Hanabergh R; Quality Professional Healthcare, Miami, Florida, USA., Gonzales-Rojas Y; Verus Clinical Research, Corp., Coconut Grove, Florida, USA., Lopez R; Bioresearch Institute LLC, Hollywood, Florida, USA., Finberg R; Department of Medicine, UMass Memorial Hospital, Worcester, Massachusetts, USA., Balboni A; Appili Therapeutics, Inc., Waterford, Virginia, USA.
المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Feb 08; Vol. 76 (3), pp. e10-e17.
نوع المنشور: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
مواضيع طبية MeSH: COVID-19*, Adult ; Humans ; SARS-CoV-2 ; Amides/therapeutic use ; Pyrazines/therapeutic use ; Antiviral Agents ; Treatment Outcome ; Randomized Controlled Trials as Topic
-
4دورية أكاديمية
المؤلفون: Montgomery H; Department of Medicine, University College London, London, UK., Hobbs FDR; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Padilla F; Centro de Investigación en Cardiología y Metabolismo, Guadalajara, Jalisco, Mexico., Arbetter D; Biometrics, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Boston, MA, USA., Templeton A; Biometrics, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, UK., Seegobin S; Biometrics, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, UK., Kim K; ARK Clinical Research, Long Beach, CA, USA., Campos JAS; Köhler & Milstein Research/Hospital Agustín O'Horán, Mérida, Yucatán, Mexico., Arends RH; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, UK., Brodek BH; Development Operations, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Brooks D; Patient Safety, Chief Medical Office, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Garbes P; Clinical Pharmacology and Quantitative Pharmacology, Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Jimenez J; Clinical Pharmacology and Quantitative Pharmacology, Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Koh GCKW; Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, UK., Padilla KW; Clinical Development, Late-stage Development, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Durham, NC, USA., Streicher K; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Viani RM; Clinical Pharmacology and Quantitative Pharmacology, Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Alagappan V; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Pangalos MN; Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, UK., Esser MT; Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA. Electronic address: mark.esser@astrazeneca.com.
مؤلفون مشاركون: TACKLE study group
المصدر: The Lancet. Respiratory medicine [Lancet Respir Med] 2022 Oct; Vol. 10 (10), pp. 985-996. Date of Electronic Publication: 2022 Jun 07.
نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE
مواضيع طبية MeSH: COVID-19 Drug Treatment*, Adult ; Antibodies, Monoclonal/therapeutic use ; Double-Blind Method ; Humans ; Middle Aged ; Outpatients ; SARS-CoV-2 ; Treatment Outcome